Windtree Therapeutics Faces Concerns About PHEXXI Manufacturing Risks

Windtree Therapeutics shares are trading lower after the company disclosed significant uncertainties and risks related to the tech transfer and manufacturing process of PHEXXI, Evofem's hormone-free contraceptive.